U.S. Stock News

NasdaqGS:LITE
NasdaqGS:LITECommunications

Did NVIDIA Deal and Optical Pivot Just Shift Lumentum Holdings' (LITE) AI Data Center Investment Narrative?

Lumentum Holdings recently highlighted how AI and cloud data centers' soaring bandwidth needs are accelerating the shift from copper to optical technologies, underpinned by a multibillion-dollar agreement with NVIDIA and new capacity coming online at its Greensboro facility from early 2028. An interesting angle is the expanding role of optical circuit switches beyond early adopters like Google, signaling a broader infrastructure transformation inside AI-focused data centers. We’ll now...
NYSE:WLY
NYSE:WLYMedia

Wiley’s New Spectral Analysis APIs Could Be A Game Changer For John Wiley & Sons (WLY)

In August 2026, Wiley launched a spectral analysis API portfolio that lets laboratories, instrument vendors, and software platforms plug directly into its extensive spectral databases, analytical algorithms, and predictive models for faster, automated compound identification and verification across fields such as pharmaceuticals, forensics, and environmental science. This move effectively turns Wiley’s long-established reference collections into an embedded data infrastructure layer for...
NYSE:WT
NYSE:WTCapital Markets

Stable Sea Tokenized Fund Expansion Might Change The Case For Investing In WisdomTree (WT)

Stable Sea Inc. recently expanded its relationship with WisdomTree Inc., adding the WisdomTree Short-Duration Income Digital Fund (WTSIX) and Floating Rate Treasury Digital Fund (FLTTX) to Stable Sea Terminal alongside the existing Treasury Money Market Digital Fund (WTGXX), giving corporate treasury teams on-platform access to three SEC-registered tokenized cash-management vehicles. This move underscores how WisdomTree is using tokenized, onchain fund structures to plug directly into...
NasdaqGS:FSLR
NasdaqGS:FSLRSemiconductor

Tougher U.S. Solar Rules And Incentives Might Change The Case For Investing In First Solar (FSLR)

In recent weeks, First Solar has benefited from strengthened U.S. policy incentives and tighter restrictions on foreign entities of concern, which together have reinforced demand for domestically produced solar modules and improved its competitive position. This policy backdrop has effectively widened First Solar's moat by making rival supply chains more complex and costly, potentially supporting stronger long-term contract terms and pricing power. We’ll now examine how these tougher U.S...
NasdaqGM:FCEL
NasdaqGM:FCELElectrical

Has FCEL’s Rally Outrun Its Fundamentals or Is FuelCell’s Profit Path Finally Emerging?

Over the past year, FuelCell Energy has seen very large stock gains as investors reacted to rapid revenue and earnings growth and signs of reduced cash burn. This enthusiasm reflects confidence in the long-term commercial uptake of its fuel cell technology, even as current valuation metrics point to an expensive stock and uncertainty around sustained profitability remains. We’ll now examine how this optimism around improved financial sustainability and growth prospects influences FuelCell...
NasdaqGS:BILI
NasdaqGS:BILIInteractive Media and Services

Bilibili (BILI) Posted Stronger Q2 Earnings, Is The Stock Still Below Fair Value?

Why Bilibili’s Latest Earnings and Buyback Caught Investor Attention Bilibili (BILI) has just reported second quarter results alongside an update on its share repurchase activity, giving investors fresh data on profitability, cash deployment, and how management is approaching capital allocation in 2026. Despite the improved net income and earnings per share that Bilibili reported for the second quarter and the completion of a US$49.11m buyback tranche, recent share price momentum has been...
NYSE:NYT
NYSE:NYTMedia

Why Is New York Times (NYT) Drawing Fresh Attention?

The New York Times (NYT) recently presented at the 5th TestMu Conference, featuring Android engineer Vanessa Johnson. The event offered a window into its product and technology priorities as investors weigh the stock after recent quarterly results. Over the past year New York Times has delivered a 15.3% total shareholder return, supported by a 59.2% total shareholder return over three years. However, the 30 day share price return is down 9% and the 90 day share price return is down 10.6%,...
NYSE:KOF
NYSE:KOFBeverage

Coca-Cola FEMSA (KOF) Gains Valuation Attention, Is The Stock Still Cheap?

Coca-Cola FEMSA. de (KOF) is back on investor radars after its recent share price move, with the stock closing at $112.58. That shift invites a closer look at its returns and fundamentals. While that latest move grabbed attention, Coca-Cola FEMSA. de has been on a stronger upward path for a while. The share price has posted an 18.71% year-to-date return and a 1-year total shareholder return of 37.92%, as dividends compound the effect of price gains. Compare Coca-Cola FEMSA. de's momentum with...
NasdaqGS:SAIA
NasdaqGS:SAIATransportation

Saia (SAIA), What Is Drawing Fresh Attention To The Stock?

Saia (SAIA) recently closed at US$352.25, giving the trucking and logistics company a market value of about US$9.37b. Investors may be weighing that price against its recent return profile and growth figures. Over the past year Saia’s share price return has been mixed, with a modest gain year to date and a recent 7 day decline of 2.73%, while the 90 day share price return is down 26.95% and the 1 year total shareholder return is 18.82%. Compare Saia’s recent pullback with other transport and...
NYSE:DCOM
NYSE:DCOMBanks

3 US Bank Stocks Built For Higher Interest Rates

With Fed chair Kevin Warsh signaling a tougher line on inflation and markets bracing for higher interest rates, investors are suddenly rethinking which stocks might benefit and which could feel pressure. This is where interest rate beneficiary financials come into focus. In this article you will see 3 stocks from our U.S. screener that appear positively exposed to this new rate backdrop, and why each one merits closer examination in the current environment. The stocks covered below are just a...
NasdaqGS:PGNY
NasdaqGS:PGNYHealthcare

Progyny (PGNY) Stock Looks Undervalued Broadly But Fairly Valued On Earnings

Progyny stock has delivered mixed results for long term holders, with the share price down about 55.0% over the past 5 years even as shorter term returns have been more resilient. At the same time, the broader valuation checks currently lean cheap, which raises questions about how to weigh that longer share price decline against what the current multiples suggest. The roughly 55.0% decline over 5 years signals that long term Progyny investors have absorbed a significant drawdown that still...
NYSE:GME
NYSE:GMESpecialty Retail

Is GameStop (GME) Cheap On Its $1.4b Convertible Notes Plan And Profit Recovery?

GameStop (GME) is back in focus after the company moved to issue US$1.4b in senior convertible notes, combined with a recent profit recovery and ongoing pressure from the shift toward digital game distribution. At a share price of US$17.87, GameStop has seen selling pressure build, with the 30 day share price return down 17.73% and the year to date share price return down 13.34%. The 1 year total shareholder return has fallen 19.32%, despite the recent profit recovery and the planned US$1.4b...
NasdaqGS:APLD
NasdaqGS:APLDIT

Applied Digital (APLD) Pushes Ahead In AI Data Centers, Is The Valuation Already Too Rich?

Investor attention has turned back to Applied Digital (APLD) after fresh commentary on its push into AI focused data center operations, where long term leases and large buildouts now sit alongside concerns about valuation and execution. Applied Digital’s share price has pulled back sharply in recent months, with a 90 day share price return down 47.14% and shorter term weakness adding to the pressure. However, the 1 year total shareholder return of 58.57% and a very large 3 year total...
NYSE:CNX
NYSE:CNXOil and Gas

CNX Resources (CNX) Could Be 4% Below Fair Value On Its Natural Gas Margin Story

CNX Resources (CNX) is back on investor radars after recent trading left the stock around $36.20. With a market value near $5.4b, the company offers a focused Appalachian natural gas profile. Over the past year, CNX Resources has seen relatively modest short term share price moves around the current US$36.20 level. At the same time, its 1 year total shareholder return of about 24% and 5 year total shareholder return above 200% point to momentum that has been building rather than...
NYSE:SCHW
NYSE:SCHWCapital Markets

Charles Schwab Stock And Other Cash Yield Plays As Treasury Rates Climb

Long term Treasury yields are surging, the U.S. national debt has crossed US$40b, and the Fed has pulled back on forward guidance, so cash and ultra short duration vehicles are back in the spotlight for investors who care about where their idle dollars sit. This article reveals three stocks exposed to these rate and liquidity cross currents and explains how each one might benefit or face pressure as conditions evolve. The three stocks below are just a starting sample, and the full screen...
NasdaqGS:DASH
NasdaqGS:DASHHospitality

DoorDash (DASH) Stock Could Trade At A Discount Despite Retail Delivery Expansion

DoorDash stock has delivered a very strong 3 year return, yet the valuation signals are split, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to a large discount while market based multiples suggest the shares are not cheap. That disconnect leaves investors weighing whether the recent share performance is aligned with the long term cash flow profile implied by the intrinsic value work. DoorDash has returned 181.7% over 3 years, which puts recent share performance well...
NYSE:CI
NYSE:CIHealthcare

How Investors Are Reacting To Cigna (CI) Linking Medical And Supplemental Benefits For High-Deductible Plans

Cigna Healthcare recently introduced an industry-first connected benefits experience that links medical and supplemental coverage for high-deductible health plans, aiming to simplify access to cash benefits for covered health events through features such as automatic claim matching via Simple File Sync Plus. This move directly targets Americans’ difficulty managing unexpected out-of-pocket medical costs and underused supplemental benefits, potentially reshaping how employees engage with...
NasdaqGS:FISV
NasdaqGS:FISVDiversified Financial

Fiserv (FISV) Could Be 56% Undervalued Following Its Q2 Earnings Miss

Fiserv (FISV) is back in focus after its Q2 earnings showed a 4.5% year on year revenue decline and a significant miss versus analyst expectations, prompting a sharp negative reaction in the stock. Against that earnings backdrop, Fiserv’s recent price action tells a cautious story. The share price return is down 18.9% year to date and about 10% over the past 90 days, while the 1 year total shareholder return has declined 61.5%, pointing to fading momentum as investors reassess growth and...
NasdaqGS:GTX
NasdaqGS:GTXAuto Components

How Stronger 2026 Outlook And Diversification Beyond Turbochargers At Garrett Motion (GTX) Has Changed Its Investment Story

Garrett Motion recently reported its second-quarter 2026 results, posting earnings of US$0.53 per share and 6.9% year-on-year net sales growth, while also lifting its full-year outlook for net sales, adjusted EBIT, and free cash flow. Alongside the stronger guidance, the company highlighted progress in commercial vehicle electric powertrain and industrial air compression programs, signaling an increasing emphasis on technologies beyond traditional light-vehicle turbochargers. Next, we’ll...
NYSE:CTS
NYSE:CTSElectronic

CTS (CTS) Could Be 13% Undervalued Following Its Distribution Expansion

Why CTS Stock Is Back On Investor Radar After Its Distribution Move CTS (CTS) has drawn fresh attention after announcing that its current sensing solutions will now be sold through authorized distribution partners serving a wide range of non automotive, high growth end markets. CTS shares have pulled back recently, with the 30 day share price return down 11.77% and the 90 day share price return down 11.46%, even though the year to date share price return is 29.01% and the 1 year total...
NYSE:GIS
NYSE:GISFood

General Mills (GIS) Stock Looks Fairly Priced While Its Broader Checks Look Weak

General Mills stock has had a tough few years, with the share price still well below where it was three years ago even after a recent rebound. For investors, the question is whether a company widely viewed as fairly valued on earnings multiples but carrying a low overall value score really offers enough compensation for that past share price weakness. Over the past three years, General Mills shareholders have seen the stock decline about 28%, which sets a cautious backdrop despite the recent...
NasdaqGM:CRSP
NasdaqGM:CRSPBiotechs

CRISPR Therapeutics (CRSP) Stock May Look Rich Following Fresh CTX310 Data

CRISPR Therapeutics stock has had a strong shorter term recovery, yet longer term holders are still sitting on a large loss, and current valuation checks lean more toward an expensive reading than a clear bargain. The share price is down about 52.7% over 5 years, which means many longer term investors are still under water even after more recent gains. Fresh Phase 1a data for CTX310 presented at the ESC Congress 2026 may support confidence in CRISPR Therapeutics drug pipeline, while clinical...
NasdaqGS:AAPL
NasdaqGS:AAPLTech

Apple (AAPL) Faces Price Hikes Chip Strain And AI Glasses Patent Lead

Apple (NasdaqGS:AAPL) adjusts pricing for its Apple TV+ and Apple One subscription bundles, increasing monthly costs for users across several tiers. The company introduces a Klarna-backed device leasing option that lets customers spread payments on Apple hardware over time. Apple experiences memory chip supply constraints as global AI demand tightens component availability for upcoming products. Independent patent reviews identify Apple as a leader in AI smart glasses filings, even without a...
NasdaqGS:NVCR
NasdaqGS:NVCRMedical Equipment

Is NovoCure (NVCR) A Bargain On Rising Earnings Estimates?

Shares of NovoCure (NVCR) have moved higher recently after analysts raised earnings estimates, with short term targets pointing to about 50.9% potential upside and a Zacks Rank #2 reflecting this sentiment. NovoCure’s recent momentum has been building, with a 30 day share price return of 20.08% and a year to date share price return of 35.82%. The 1 year total shareholder return of 44.53% contrasts with weaker total shareholder returns over three and five years. Compare NovoCure's recent...